This study is currently not recruiting participants.
A Phase III Randomized Double-Blind Placebo-Controlled Multi-Center Study of Panobinostat for Maintenance of Response in Patients with Hodgkin's Lymphoma Who are at Risk for Relapse After High Dose Chemotherapy and Autologous Stem Cell Transplant
Not Recruiting
18 years - 100 years
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Hodgkin's Lymphoma
Age:
18 years - 100 years
Gender: All
Updated on
16 Sep 2011.
Study ID: 1105005654 (1007-07)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
